Intranasal Ketamine Succeeds for Resistant Depression in Phase 3 Trial - Medscape

Submitted by Anonymous (not verified) on Fri, 05/11/2018 - 14:22

MedscapeIntranasal Ketamine Succeeds for Resistant Depression in Phase 3 TrialMedscape... received the standard of care," presenting author Vanina Popova, MD, study-responsible physician at Janssen Research and Development, Belgium, told Medscape Medical News here at the American Psychiatric Association (APA) 2018 annual meeting.